Alumis Inc. (ALMS)
$23.03-4.72%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.8B
- Avg volume
- 1.2M
- Beta
- -0.67
- P/E (TTM)
- -6.06
- Short % float
- 6.72%
- Days to cover
- 6.1
- SI change
- -14.8%
- 1W
- -9.69%
- 1M
- -17.75%
- 3M
- +4.59%
- YTD
- +157.03%
- vs SPY 1W
- -8.50%
- vs SPY 1M
- -21.07%
- vs SPY 3M
- +2.20%
- vs SPY YTD
- +145.28%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- NAMSSELLNewAmsterdam Pharma Company N.V.RECOVERYQ 29$26.85-3.66%
- OVIDBUYOvid Therapeutics Inc.RECOVERYQ -8$2.82+0.71%
- VRAXSELLVirax Biolabs Group LimitedRECOVERYQ -25$3.00-5.96%
- LFWDSELLLifeward Ltd.RECOVERYQ -16$7.29-0.41%
- PARKBUYPark Dental Partners, Inc. Common StockQ 80$20.74+0.63%
- PBLSBUYParabilis Medicines, Inc.Q 72$38.43-2.36%
- TRDABUYEntrada Therapeutics, Inc.RECOVERYQ -13$7.33-3.17%
- CVMBUYCEL-SCI CorporationCRISISQ 4$1.38-2.82%
- RVPBUYRetractable Technologies, Inc.RECOVERYQ 7$0.73+0.00%
- MAZESELLMaze Therapeutics, Inc.RECOVERYQ 40$29.60+0.58%
- TWSTBUYTwist Bioscience CorporationBULLQ 30$140.80-3.29%
- INCRBUYInterCure Ltd.RECOVERYQ 7$5.48+28.64%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 3
- GROWTH
- 19
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-61.8%
REV YoY-
ROE-103.0%
EPS YoY-
ROA-78.3%
GROSS88
OP-6204
NET-5933
[VALUATION]
P/E TTM-6.06
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B6.50
P/FCF-
EV/EBITDA-6.36
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E8.06
ALTMAN Z-
CURR RATIO6.74
ND/EBITDA-
BETA-0.67
